Li M, Wulayin K, Lin S, Wu C, Chen L
Liver Res. 2025; 7(4):361-364.
PMID: 39958777
PMC: 11791916.
DOI: 10.1016/j.livres.2023.11.001.
Auty S, Griffith K, Shafer P, Gee R, Conti R
J Health Polit Policy Law. 2022; 47(6):691-708.
PMID: 35867531
PMC: 9789167.
DOI: 10.1215/03616878-10041121.
Hawkins K, Hot I
J Pharm Technol. 2021; 34(5):199-203.
PMID: 34860992
PMC: 6109861.
DOI: 10.1177/8755122518782478.
Yelemkoure E, Yonli A, Sombie H, Tao I, Zoure A, Ouattara A
Intervirology. 2021; 65(3):151-159.
PMID: 34583364
PMC: 9501785.
DOI: 10.1159/000519848.
McCabe L, White I, Vinh Chau N, Barnes E, Pett S, Cooke G
Trials. 2020; 21(1):413.
PMID: 32423467
PMC: 7236096.
DOI: 10.1186/s13063-020-04350-x.
The Role of PD-1 in Acute and Chronic Infection.
Jubel J, Barbati Z, Burger C, Wirtz D, Schildberg F
Front Immunol. 2020; 11:487.
PMID: 32265932
PMC: 7105608.
DOI: 10.3389/fimmu.2020.00487.
Real life efficacy and safety of direct-acting antiviral therapy for treatment of patients infected with hepatitis C virus genotypes 1, 2 and 3 in northwest China.
Yang Y, Wu F, Wang W, Shi J, Li Y, Zhang X
World J Gastroenterol. 2019; 25(44):6551-6560.
PMID: 31802834
PMC: 6886016.
DOI: 10.3748/wjg.v25.i44.6551.
Hepatitis C Virus among Female Sex Workers: A Cross-Sectional Study Conducted along Rivers and Highways in the Amazon Region.
Oliveira-Filho A, Aires D, Cavalcante N, Raiol N, Lisboa B, Frade P
Pathogens. 2019; 8(4).
PMID: 31739623
PMC: 6963267.
DOI: 10.3390/pathogens8040236.
Incidence of hepatocellular carcinoma among older Americans attributable to hepatitis C and hepatitis B: 2001 through 2013.
Shiels M, Engels E, Yanik E, McGlynn K, Pfeiffer R, OBrien T
Cancer. 2019; 125(15):2621-2630.
PMID: 30980394
PMC: 6625871.
DOI: 10.1002/cncr.32129.
HIV and hepatitis C virus infections in Quebec's provincial detention centres: comparing prevalence and related risky behaviours between 2003 and 2014-2015.
Courtemanche Y, Poulin C, Serhir B, Alary M
Can J Public Health. 2018; 109(3):353-361.
PMID: 29981093
PMC: 6964431.
DOI: 10.17269/s41997-018-0047-4.
Sofosbuvir/Velpatasvir/Voxilaprevir: A Review in Chronic Hepatitis C.
Heo Y, Deeks E
Drugs. 2018; 78(5):577-587.
PMID: 29546556
DOI: 10.1007/s40265-018-0895-5.
Ledipasvir/Sofosbuvir: A Review in Chronic Hepatitis C.
Scott L
Drugs. 2018; 78(2):245-256.
PMID: 29380288
DOI: 10.1007/s40265-018-0864-z.
The 5BSL3.2 Functional RNA Domain Connects Distant Regions in the Hepatitis C Virus Genome.
Romero-Lopez C, Berzal-Herranz A
Front Microbiol. 2017; 8:2093.
PMID: 29163393
PMC: 5671509.
DOI: 10.3389/fmicb.2017.02093.
Efficacy of a 3C-like protease inhibitor in treating various forms of acquired feline infectious peritonitis.
Pedersen N, Kim Y, Liu H, Galasiti Kankanamalage A, Eckstrand C, Groutas W
J Feline Med Surg. 2017; 20(4):378-392.
PMID: 28901812
PMC: 5871025.
DOI: 10.1177/1098612X17729626.
Functional RNA structures throughout the Hepatitis C Virus genome.
Adams R, Pirakitikulr N, Pyle A
Curr Opin Virol. 2017; 24:79-86.
PMID: 28511116
PMC: 5529263.
DOI: 10.1016/j.coviro.2017.04.007.
Resistance Mechanisms in Hepatitis C Virus: implications for Direct-Acting Antiviral Use.
Bagaglio S, Uberti-Foppa C, Morsica G
Drugs. 2017; 77(10):1043-1055.
PMID: 28497432
DOI: 10.1007/s40265-017-0753-x.